[go: up one dir, main page]

EP0759427A4 - Process for producing halogenated beta-lactam compounds - Google Patents

Process for producing halogenated beta-lactam compounds

Info

Publication number
EP0759427A4
EP0759427A4 EP96904294A EP96904294A EP0759427A4 EP 0759427 A4 EP0759427 A4 EP 0759427A4 EP 96904294 A EP96904294 A EP 96904294A EP 96904294 A EP96904294 A EP 96904294A EP 0759427 A4 EP0759427 A4 EP 0759427A4
Authority
EP
European Patent Office
Prior art keywords
beta
group
lactam
substituent
hydrogen atom
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
EP96904294A
Other languages
German (de)
French (fr)
Other versions
EP0759427B1 (en
EP0759427A1 (en
Inventor
Sigeru Torii
Hideo Tanaka
Michio Sasaoka
Daisuke Suzuki
Yutaka Kameyama
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Otsuka Chemical Co Ltd
Original Assignee
Otsuka Chemical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Chemical Co Ltd filed Critical Otsuka Chemical Co Ltd
Publication of EP0759427A1 publication Critical patent/EP0759427A1/en
Publication of EP0759427A4 publication Critical patent/EP0759427A4/en
Application granted granted Critical
Publication of EP0759427B1 publication Critical patent/EP0759427B1/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
    • C07D205/085—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams with a nitrogen atom directly attached in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
    • C07D205/09—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams with a sulfur atom directly attached in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
    • C07D205/09—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams with a sulfur atom directly attached in position 4
    • C07D205/095—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams with a sulfur atom directly attached in position 4 and with a nitrogen atom directly attached in position 3
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Cephalosporin Compounds (AREA)
  • Hydrogenated Pyridines (AREA)

Abstract

A process for preparing a beta -lactam halide compound represented by the formula (2) characterized by halogenating the allenyl group of an allenyl beta -lactam compound represented by the formula (1) with a cupric halide and a metal halide to obtain the beta -lactam halide compound <CHEM> wherein R<1> is a hydrogen atom or amino or protected amino, R<2> is a hydrogen atom, halogen atom, lower alkoxyl, lower acyl, or lower alkyl having a hydroxyl group or protected hydroxyl group as a substituent, R<3> is a hydrogen atom or carboxylic acid protecting group, and R<4> is a hydrocarbon group which may have a substituent, or the group -S-S(O)n-Ar, n being 0 to 2, Ar being aryl which may have a substituent <CHEM> wherein R<1>, R<2>, R<3> and R<4> are the same as defined above, X and Y are each halogen atom.
EP96904294A 1995-03-10 1996-03-01 Process for producing halogenated beta-lactam compounds Expired - Lifetime EP0759427B1 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP07948995A JP3775820B2 (en) 1995-03-10 1995-03-10 Method for producing halogenated β-lactam compound
JP79489/95 1995-03-10
JP7948995 1995-03-10
PCT/JP1996/000489 WO1996028421A1 (en) 1995-03-10 1996-03-01 PROCESS FOR PRODUCING HALOGENATED β-LACTAM COMPOUNDS

Publications (3)

Publication Number Publication Date
EP0759427A1 EP0759427A1 (en) 1997-02-26
EP0759427A4 true EP0759427A4 (en) 1998-07-08
EP0759427B1 EP0759427B1 (en) 2003-07-02

Family

ID=13691324

Family Applications (1)

Application Number Title Priority Date Filing Date
EP96904294A Expired - Lifetime EP0759427B1 (en) 1995-03-10 1996-03-01 Process for producing halogenated beta-lactam compounds

Country Status (6)

Country Link
US (1) US6011151A (en)
EP (1) EP0759427B1 (en)
JP (1) JP3775820B2 (en)
AT (1) ATE244218T1 (en)
DE (1) DE69628887T2 (en)
WO (1) WO1996028421A1 (en)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2615693A1 (en) * 1975-04-11 1976-10-28 Bristol Myers Canada Ltd ANTIBACTERIAL AGENTS AND METHOD FOR MANUFACTURING THEREOF
EP0215435A1 (en) * 1985-09-09 1987-03-25 Otsuka Pharmaceutical Co., Ltd. 2-Oxa-isocephem compounds, compositions containing same and processes for preparing same
WO1996028453A1 (en) * 1995-03-10 1996-09-19 Otsuka Kagaku Kabushiki Kaisha Processes for the production of 2-isocephem derivatives

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4918832A (en) * 1972-06-19 1974-02-19
US4013648A (en) * 1975-07-23 1977-03-22 Bristol-Myers Company Δ2,3 -0-2-Isocephem-4-carboxylic acid and derivatives as antibacterial agents
US5196530A (en) * 1991-03-11 1993-03-23 Otsuka Kagaku Kabushiki Kaisha Process for preparing 2-exo-methylenepenam derivatives
JP3195371B2 (en) * 1991-03-11 2001-08-06 大塚化学株式会社 Method for producing cefm derivatives
JP3224279B2 (en) * 1992-07-27 2001-10-29 大塚化学株式会社 Method for producing cefm compound

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2615693A1 (en) * 1975-04-11 1976-10-28 Bristol Myers Canada Ltd ANTIBACTERIAL AGENTS AND METHOD FOR MANUFACTURING THEREOF
EP0215435A1 (en) * 1985-09-09 1987-03-25 Otsuka Pharmaceutical Co., Ltd. 2-Oxa-isocephem compounds, compositions containing same and processes for preparing same
WO1996028453A1 (en) * 1995-03-10 1996-09-19 Otsuka Kagaku Kabushiki Kaisha Processes for the production of 2-isocephem derivatives
EP0759437A1 (en) * 1995-03-10 1997-02-26 Otsuka Kagaku Kabushiki Kaisha Processes for the production of 2-isocephem derivatives

Also Published As

Publication number Publication date
EP0759427B1 (en) 2003-07-02
EP0759427A1 (en) 1997-02-26
WO1996028421A1 (en) 1996-09-19
ATE244218T1 (en) 2003-07-15
JPH08245574A (en) 1996-09-24
US6011151A (en) 2000-01-04
DE69628887D1 (en) 2003-08-07
JP3775820B2 (en) 2006-05-17
DE69628887T2 (en) 2004-04-15

Similar Documents

Publication Publication Date Title
TW254943B (en)
NO992549L (en) Sugar compound, gelling agent and process for preparation thereof
AU679859B2 (en) Novel compound, process for producing the same, and antitumor agent
AU747521C (en) Cycloalkene derivatives, process for producing the same, and use
ATE201687T1 (en) GALANTHAMIN DERIVATIVE, A METHOD FOR THE PRODUCTION THEREOF AND ITS USE AS A MEDICATION
TW230750B (en)
DE69319764D1 (en) Process for the preparation of beta-lactam derivatives and intermediate for their synthesis
EP0759427A4 (en) Process for producing halogenated beta-lactam compounds
EP0623622A4 (en) Process for producing cephem compound.
EP1028118A4 (en) Process for producing 3-cephem compounds
EP0590681A3 (en) A process for the preparation of aminothiadiazolylacetyl halide derivatives
DE69225651D1 (en) USE OF HALOGENATED BETA LACTAMES FOR THE PRODUCTION OF 3-HYDROXYCEPHEM DERIVATIVES
AU669507B2 (en) Process for producing 4-substituted azetidinone derivatives
EP0827961A4 (en) Process for the preparation of beta-lactam compounds
HUT54111A (en) Process for producing carbamates
EP0844247A4 (en) Process for producing 3-norcephem compounds
ATE167474T1 (en) METHOD FOR PRODUCING N-ALKYLPYRAZOLES
EP0638552A4 (en) Process for synthesizing 4-substituted azetidinone derivative.
GR3024010T3 (en) Process for preparing sulfonamide derivative of norbornane
ATE210115T1 (en) METHOD FOR PRODUCING (1&#39;R,3S,4R)4-ACYLTHIOAZETIDINONES

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19961108

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT DE FR GB IT

RHK1 Main classification (correction)

Ipc: C07D205/095

A4 Supplementary search report drawn up and despatched

Effective date: 19980526

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT DE FR GB IT

17Q First examination report despatched

Effective date: 19991122

GRAH Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOS IGRA

GRAH Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOS IGRA

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

AK Designated contracting states

Designated state(s): AT DE FR GB IT

REG Reference to a national code

Ref country code: GB

Ref legal event code: FG4D

REF Corresponds to:

Ref document number: 69628887

Country of ref document: DE

Date of ref document: 20030807

Kind code of ref document: P

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: GB

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20040301

Ref country code: AT

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20040301

ET Fr: translation filed
PLBE No opposition filed within time limit

Free format text: ORIGINAL CODE: 0009261

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT

26N No opposition filed

Effective date: 20040405

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: DE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20041001

GBPC Gb: european patent ceased through non-payment of renewal fee
PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: FR

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20041130

REG Reference to a national code

Ref country code: FR

Ref legal event code: ST

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IT

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20050301